A global fight against Covid-19
Given the COVID-19 pandemic, Royals Cup has had to innovate to adapt to the current circumstances. Staying true to our traditions, #RC21 Royals Run provides our participants with an opportunity to engage in sports activities and compete against European business schools! As part of the Royals Run, we are fundraising for Gavi – The Vaccine Alliance to contribute to the global fight against COVID-19.
Gavi uses vaccines as an integral part of their mission to reduce poverty, save lives and protect our world against the threat of epidemics. Working together with governments, Gavi implements vaccination programmes into their healthcare systems to immunize their populations against virulent diseases. As children become healthier, families, communities, and countries gain more economic prosperity and social stability. For every $1 Gavi spends on vaccines, $21 future costs of health care, loss in wage and loss in productivity are saved!
Partnering with several key actors in the global health sector, and drawing on their respective strengths, has given way to the successes and impacts of Gavi. Engaging the relevant stakeholders into their model, Gavi provides equitable access to a wide portfolio of safe and effective vaccines. Through the alliance, Gavi has gained negotiating powers to allow the purchasing of vaccines at prices affordable to the poorest countries. This has enabled Gavi-supported countries to immunise children with all 11-WHO recommended childhood vaccines for only $28, in comparison to $1,200 for the same vaccines in the United States!
Gavi is co-leading the COVAX initiative. This is the vaccine pillar of the Access to COVID-19 (ACT) Accelerator, which is a global cooperative to fight and tackle the ongoing COVID-19 pandemic. Together with its partners, Gavi is working towards the acceleration and development of COVID-19 vaccines and to guarantee fair and equitable access to these vaccines for every country in the world. The COVAX Facility invests in a wide portfolio of COVID-19 vaccine candidates and is pooling purchasing powers of participating countries for rapid access to vaccines that receive regulatory approval. In addition, it provides 92 lower-income countries with financial instruments to support the participation in the COVAX Facility to ensure access to vaccines regardless of income level. COVAX is also working towards country readiness and delivery by ensuring that the appropriate infrastructure and technical support is in place for vaccination efforts.